TD Waterhouse Canada 13F: Adds $20M to MetLife (MET) Stake
Key Points
- TD Waterhouse Canada boosted its stake in MetLife, Inc. by 136.5%, growing its holdings to 373,636 shares valued at about $35.3 million.
- MetLife shares traded recently around $99.58, down about 1.2% since the filing date when the stock closed at $100.76.
- The life insurance giant posts a trailing P/E ratio of 19.3 and an annual dividend rate of $2.37 per share.
Since the filing, $MET is down 1.2% to date (from the $100.76 close on Oct 16, 2026).
Get MetLife text alerts
We text you when insiders, Congress, analysts or big funds move on $MET.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated MetLife, Inc. alert may contain errors. Disclosures
TD Waterhouse Canada disclosed a major addition to its portfolio, boosting its stake in MetLife, Inc. (NYSE:MET) by 136.5% in a filing on October 16, 2026. The institutional investor bought an additional 215,666 shares during the period, bringing its total holdings to 373,636 shares. The reported value of the position reached approximately $35.3 million.
MET
MetLife, Inc.
TD Waterhouse Canada vs. the S&P 500
Hypothetical returns from TD Waterhouse Canada's disclosed trades, not real profit or advice. How we model this.
What Changed in TD Waterhouse Canada's MetLife Position
The fund expanded its previous position of 157,970 shares up to 373,636 shares. That change represents a 136.5% increase in share count for the quarter.
Other Institutional Activity in MetLife
Other large funds made adjustments to their positions around the same time. TCV Trust & Wealth Management took a new position by acquiring 2,491 shares worth about $234,551. Dodge & Cox Inc. reduced its holdings by 2,683,520 shares, ending with 48,431,150 shares worth about $4.82 billion. Pzena Investment Management LLC trimmed its stake by 1,72950 shares, leaving it with 11,130,983 shares valued at roughly $1.11 billion.
MetLife, Inc. Stock Down 1.2%
MetLife shares recently traded around $99.58, sitting about 1.2% below the $100.76 close recorded on the filing date of October 16, 2026. The stock sits above both its 50-day moving average of $96.91 and its 200-day moving average of $84.73. The share price trades roughly 2.8% below its 52-week high of $102.43 and well above its 52-week low of $67.33. Analysts hold a consensus buy rating on the company with a mean price target of $107.38.
Recent Earnings
MetLife generated trailing twelve-month revenue of $79.40 billion alongside basic earnings per share of $5.16. The insurer reported a return on equity of 13.1% and a net margin of 4.6%. The company's next earnings report is scheduled for November 4, 2026.
Dividend
The company pays an annual dividend rate of $2.37 per share, yielding 2.38%. Its dividend payout ratio stands at 44.0%.
Insider Buying and Selling at MetLife, Inc.
Director Mark Weinberger acquired 587 shares on June 16, 2026.
Analysts Set New Price Targets
UBS maintained its Buy rating on October 6, 2026, lifting its price target to $110.00 from $105.00. Mizuho kept an Outperform rating on October 7, 2026, adjusting its target to $109.00 from $112.00. Barclays maintained an Overweight rating on October 7, 2026, raising its target to $111.00 from $97.00. Wells Fargo maintained an Overweight rating on October 12, 2026, setting a $110.00 target. JP Morgan kept an Overweight rating on October 15, 2026, setting a $110.00 target. The stock carries a consensus buy recommendation from 16 analyst opinions.
About MetLife
Headquartered in New York, MetLife provides insurance, annuities, employee benefits, and asset management services to customers worldwide. The financial services firm operates across several segments, including group benefits, retirement solutions, and regional markets in Asia, Latin America, and Europe. Institutional portfolio moves in the stock reflect ongoing portfolio balancing across the insurance sector.
Bottom Line
Investors are keeping an eye on MetLife ahead of its upcoming earnings release scheduled for November 4, 2026. Institutional filing updates continue to offer insight into how large asset managers position their portfolios within the insurance industry.
Related Filing Alerts
Source: TD Waterhouse Canada's 13F filing on $MET (Oct 16, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts